Skip to main content
SpringerLink
Log in

Long-acting pasireotide dominates for agromegaly

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. International Society for Pharmacoeconomics and Outcomes Research

Reference

  • Hahl J, et al. Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization. 18th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PDB70, 7 Nov 2015. Available from: URL: http://www.ispor.org/research_study_digest/list.asp?qs=42937

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Long-acting pasireotide dominates for agromegaly. PharmacoEcon Outcomes News 742, 24 (2015). https://doi.org/10.1007/s40274-015-2652-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2652-2

Search

Navigation